Chemocentryx Fundamentals

CCXI -  USA Stock  

USD 17.19  0.11  0.64%

Chemocentryx fundamentals help investors to digest information that contributes to Chemocentryx's financial success or failures. It also enables traders to predict the movement of Chemocentryx Stock. This fundamental analysis module provides a way for investors to measures Chemocentryx's intrinsic value by examining all of its available economic and financial indicators and drivers, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chemocentryx stock. Please note, this module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Search Fundamentals 

 
Refresh
Chemocentryx Interest Expense is most likely to increase significantly in the upcoming years. The last year's value of Interest Expense was reported at 2.64 Million. The current Selling General and Administrative Expense is estimated to increase to about 45.5 M, while Consolidated Income is projected to decrease to (56.8 M).

Chemocentryx Price to Earning Analysis

Chemocentryx's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
 2018 2019 2020 2021 (projected)
Interest Expense1.22 M2.15 M2.64 M2.85 M
Gross Profit42.88 M36.13 M64.89 M54.5 M
P/E 
 = 
Market Value Per Share 
Earnings Per Share 
More About Price to Earning | All Equity Analysis

Current Chemocentryx Price to Earning

    
  40.53 X  
Most of Chemocentryx's fundamental indicators, such as Price to Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chemocentryx is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Chemocentryx Price to Earning Historical Pattern

Today, most investors in Chemocentryx Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Chemocentryx's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to earning growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Chemocentryx price to earning as a starting point in their analysis.
 Chemocentryx Price to Earning 
Share
      Timeline 
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Compare to competition

Chemocentryx Accumulated Retained Earnings Deficit

Accumulated Retained Earnings Deficit

(498.11 Million)Share
Chemocentryx Accumulated Retained Earnings Deficit are most likely to decrease significantly in the upcoming years. The last year's value of Accumulated Retained Earnings Deficit was reported at (485.34 Million)
Based on the latest financial disclosure, the price to earning indicator of Chemocentryx is roughly 40.53 times. This is 56.85% higher than that of the Healthcare sector and notably higher than that of the Biotechnology industry. The price to earning for all United States stocks is 41.12% lower than that of the firm.

Chemocentryx Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Chemocentryx's current stock value. Our valuation model uses many indicators to compare Chemocentryx value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Chemocentryx competition to find correlations between indicators driving Chemocentryx's intrinsic value. More Info.
Chemocentryx is number one stock in profit margin category among related companies. It is number one stock in current ratio category among related companies . . Chemocentryx Profit Margin is most likely to increase slightly in the upcoming years. The last year's value of Profit Margin was reported at -0.85

Chemocentryx Current Valuation Drivers

We derive many important indicators used in calculating different scores of Chemocentryx from analyzing Chemocentryx's financial statements. These drivers represent accounts that assess Chemocentryx's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Chemocentryx's important valuation drivers and their relationship over time.
201620172018201920202021 (projected)
Net Income Per Employee(642.8 K)270.59 K(499.55 K)(676.7 K)(415.07 K)(447.84 K)
Average Assets124.81 M152.54 M190.61 M223.14 M447.82 M483.18 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(39.62 M)18.28 M(36.23 M)(51.7 M)(49.95 M)(51.26 M)
Earnings Before Interest Taxes and Depreciation Amortization USD(39.62 M)18.28 M(36.23 M)(51.7 M)(49.95 M)(51.26 M)
Earnings before Tax(39.96 M)17.86 M(37.97 M)(55.49 M)(55.36 M)(56.81 M)
Average Equity55.9 M50.95 M22.66 M69.99 M317.93 M343.03 M
Enterprise Value339.9 M272.2 M541.85 M2.29 B4.29 B4.63 B
Free Cash Flow38.84 M4.16 M15.6 M(70.91 M)(96.55 M)(99.09 M)
Invested Capital105.51 M121.05 M110.52 M131.18 M498.12 M537.44 M
Invested Capital Average85.79 M87.97 M98.42 M135.44 M323.79 M349.35 M
Market Capitalization353.76 M290.16 M551.24 M2.3 B4.29 B4.62 B
Tangible Asset Value155.87 M189.33 M183.31 M209.08 M518.9 M559.86 M
Working Capital110.36 M146.89 M116.99 M115.28 M390.01 M420.8 M

Chemocentryx Fundamentals

About Chemocentryx Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Chemocentryx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chemocentryx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chemocentryx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2021
Deferred Revenue36.6 M54.5 M
Revenues64.9 M54.5 M
Revenue to Assets 0.13  0.18 
Revenue Per Employee486.6 K450.8 K
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in Mountain View, California. Chemocentryx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 133 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Chemocentryx without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Idea Analyzer Now

   

Idea Analyzer

Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
All  Next Launch Module

Pair Trading with Chemocentryx

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemocentryx position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemocentryx will appreciate offsetting losses from the drop in the long position's value.

Chemocentryx Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Chemocentryx and Dynavax Technologies. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Trending Equities. Note that the Chemocentryx information on this page should be used as a complementary analysis to other Chemocentryx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for Chemocentryx Stock analysis

When running Chemocentryx price analysis, check to measure Chemocentryx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemocentryx is operating at the current time. Most of Chemocentryx's value examination focuses on studying past and present price action to predict the probability of Chemocentryx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chemocentryx's price. Additionally, you may evaluate how the addition of Chemocentryx to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
The market value of Chemocentryx is measured differently than its book value, which is the value of Chemocentryx that is recorded on the company's balance sheet. Investors also form their own opinion of Chemocentryx's value that differs from its market value or its book value, called intrinsic value, which is Chemocentryx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemocentryx's market value can be influenced by many factors that don't directly affect Chemocentryx underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemocentryx's value and its price as these two are different measures arrived at by different means. Investors typically determine Chemocentryx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemocentryx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.